HRNR and neoplasm: To confirm hornerin knockdown in the tumor endothelium, we performed quantitative PCR (qPCR) on fluorescence-activated cell sorting (FACS) sorted tumor CD31+CD45− cells and observed a marked 78% reduction in hornerin transcript in the Hrnr siRNA-treated cohort (Fig. 3b).